Page last updated: 2024-09-04

beta-lactams and cyclosporine

beta-lactams has been researched along with cyclosporine in 2 studies

Compound Research Comparison

Studies
(beta-lactams)
Trials
(beta-lactams)
Recent Studies (post-2010)
(beta-lactams)
Studies
(cyclosporine)
Trials
(cyclosporine)
Recent Studies (post-2010) (cyclosporine)
7,5791793,39530,5473,8026,558

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Acharya, S; Anderson, SJ; Arnold, LF; Berg, CA; Carlson, SA; Choudhary, S; de la Rosa, BM; Feye, KM; Hu, HZ; Izbicki, P; Jefferson, MA; Kanuri, SH; Kleinhenz, MD; Kondru, NC; Lange, JK; Luna, KC; Luo, D; Malovic, E; Manne, S; Massey, N; Mlynarczyk, GSA; Putra, MR; Schmidt-McCormack, GR; Sharma, S; Smith, JS; Wehrman, RF1
Kishimoto, K; Matsuse, H; Nakayama, H; Oshio, T1

Reviews

1 review(s) available for beta-lactams and cyclosporine

ArticleYear
Off-Target drug effects resulting in altered gene expression events with epigenetic and "Quasi-Epigenetic" origins.
    Pharmacological research, 2016, Volume: 107

    Topics: Amino Acid Transport System X-AG; Analgesics, Opioid; Anti-Bacterial Agents; beta-Lactams; Cyclosporine; Epigenesis, Genetic; Gene Expression Regulation; Immunosuppressive Agents; Lithium Compounds; Neuroprotective Agents; Receptors, Opioid

2016

Other Studies

1 other study(ies) available for beta-lactams and cyclosporine

ArticleYear
[A CASE OF PULMONARY MYCOBACTERIUM ABSCESSUS INFECTION THAT DEVELOPED DURING IMMUNOSUPPRESSIVE THERAPY FOR MYASTHENIA GRAVIS WITH RECURRENT THYMOMA].
    Kekkaku : [Tuberculosis], 2016, Volume: 91, Issue:2

    Topics: Anti-Bacterial Agents; beta-Lactams; Clarithromycin; Cyclosporine; Drug Therapy, Combination; Glucocorticoids; Humans; Immunocompromised Host; Immunosuppressive Agents; Levofloxacin; Male; Middle Aged; Myasthenia Gravis; Mycobacterium Infections, Nontuberculous; Neoplasm Recurrence, Local; Thymoma; Thymus Neoplasms; Treatment Outcome

2016